| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.087 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |